ANTICUAGULANT A.Rahimzadeh.B.sc,M.sc Shahid Beheshty university

Slides:



Advertisements
Similar presentations
Ramon C. Mora M.D. Year Graduated : 1985
Advertisements

CRRT Continue Renal Replacement Therapy
Definition Continuous Renal Replacement Therapy (CRRT)
MANAGEMENT OF CONTINUOUS HEMODIALYSIS
End Stage Renal Disease in Children. End stage kidney disease occurs when the kidneys are no longer able to function at a level that is necessary for.
Continuous Renal Replacement Therapy. Why continuous Therapies? Continuous therapies closely mimic the GFR of native kidneys Large amounts of fluid.
Clinical Calculation 5th Edition
Selected Clinical Calculations
Exit skill for Heparin Administration
Strategies for Improving Adequacy Decreasing the Risk of Premature Death Educate Your Dialysis Team Review Proper Procedure for Drawing Lab Samples - Lab.
HEMODIALYSIS ADEQUACY HEMODIALYSIS ADEQUACY Laurie Vinci RN, BSN, CNN Laurie Vinci RN, BSN, CNN September 17, 2011 September 17, 2011.
Heparin in CRRT Benan Bayrakci, McLean Antitrombin 3 Inactive Thrombin (IIa) V, VIII, XIII, Fibrinogen Inactive Factor Xa Common Pathway Inactive.
Venous Thromboembolism Prevention August Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for.
ANAESTHESIA AND ANTICOAGULANTS
Dr msaiem Acquired Coagulation Disorders Dr Mohammed Saiem Al-dahr KAAU Faculty of Applied Medical Sciences.
Calculating Heparin Bolus Dosage and IV Rate
A bleeding diathesis has been recognized in pt. with CCHD, a variety of coagulation abnormalities has been postulated: 1- Polycythemia 2- Hyper viscosity.
NURS 1950 Pharmacology I 1.  Objective 1: identify general reasons anticoagulants are given 2.
Continuous Renal Replacement Therapy -CRRT
ANTICOAGULATION IN CONTINUOUS RENAL REPLACEMENT THERAPY Dawn M Eding RN BSN CCRN Pediatric Critical Care Helen DeVos Children's Hospital.
April 23, 2015 Mini-Lecture Nathan King M.D. Anticoagulation Reversal Part 2: UFH & LMWH.
The Clinical Guide “A Guide to Implementing Renal Best Practice in Haemodialysis“ Chapter 5: Anticoagulation Team Leader: Angela Henson Co-authors: Franta.
What form of anticoagulation is the “best” Or why is Citrate better then Heparin or Prostacyclin.
Practical Considerations for CRRT Helen Currier RN, BSN, CNN Nancy McAfee RN, BSN, CNN.
Anticoagulation in CRRT
Experiences with plasmapheresis in our pediatric dialysis unit L. Koster-Kamphuis, E. Cornelissen, E. Levtchenko, N. van de Kar Dept. of Pediatric Nephrology.
Common Prescription Errors in Pediatric CRRT: a “Top 10 List” Jordan M. Symons, MD University of Washington School of Medicine Seattle Children’s Hospital.
Brophy University of Iowa Pediatric CRRT Anticoagulation Patrick Brophy MD Director Pediatric Nephrology University of Iowa- Children’s Hospital PCRRT.
Citrate Anticoagulation
Good Morning 6 June Uremic Bleeding: Pathogenesis and Therapy 麻醉科 林子富.
Hemodialysis Prescription Shahram Taheri M.D. Associate of Prof. Isfahan School of Medicine.
Complications of Pediatric CRRT Theresa A. Mottes RN Pediatric Dialysis/Research Nurse C.S. Mott Children’s Hospital University of Michigan.
Agents Affecting Blood Clotting
Proposal of a flow-chart to avoid circuit clotting in prolonged intermittent renal replacement therapy (PIRRT): a monocentric experience 1 Vincenzo Cantaluppi,
Chapter 19 Agents affecting Blood Clotting. Blood Clotting p461 Clotting is necessary to prevent fatal loss of blood from a minor injury Thromboemboli.
Continuous Renal Replacement Therapy Developed by: Critical Care and Hemodialysis Educators, February 2009 King Faisal Specialist Hospital and Research.
Anticoagulants Course: Pharmacology I Course Code: PHR 213 Course Instructor: Sabiha Chowdhury Lecturer Department of Pharmacy BRAC University.
Hemodialysis.
Management Control or elimination of the underlying cause Severe DIC: – Control of hemodynamic parameters – Respiratory support – Surgery Attempts to treat.
Coagulation and anti-coagulants March Normal physiology Patophysiology Diagnostic tests Anticoagulants Anticoagulants and anesthesia.
Systemic anticoagulation during ECMO is intended to control thrombin generation and limit the risk for thrombotic and hemorrhagic complications.
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
Hemodialysis: Core Curriculum 2014 Am J Kidney Dis. 2014;63(1): 위지완.
신장내과 R4 김효식 /Prof. 전진석 혈액투석의 시작. Dialysis start Patients with eGFR >15 mL/min/1.73 m 2 Generally do not initiate chronic dialysis for such patients, ev.
ANTICOAGULATION IN HAEMODIALYSIS
23 Anticoagulants.
Consultant nephrologist Shirbin General Hospital
Continuous renal replacement therapy
Yadegarynia, D. MD..
Anticoagulation Monitoring Shouldn’t We Validate?
Nephrology Specialist at New Mansoura General Hospital
RENAL REPLACEMENT THERAPIES
Blood Transfusion The reason for a progressive blood sampling strategy by FIS should be considered in the light of the Lahti CC Worlds in 2001 where six.
Volume 63, Issue 4, Pages (April 2003)
Heparin Infusion Calculations
CITRATE ANTICOAGULATION IMPROVES BLOOD COMPATIBILITY IN DIALYSIS AND APERESIS – DATA FROM IN VITRO EXPERIMENTS S. Harm, J. Hartmann Center for Biomedical.
Hemodialysis in 20 kg Patient with AKI and Sepsis
Pediatric Intravenous Medications
Coagulation Cascade of the Newborn
Nursing Issues in Pediatric CRRT
Nephrology Skills Laboratory
Disseminated intravascular coagulation (DIC)
23 Anticoagulants.
Renal replacement therapy
Copyright © 2015 NIKKISO Co., LTD. All rights reserved.
Volume 63, Issue 4, Pages (April 2003)
Venous air embolism may arise from 4 possible areas of air entry into the dialysis circuit. Venous air embolism may arise from 4 possible areas of air.
Introduction to IV Therapy
Pediatric Intravenous Medications
Presentation transcript:

ANTICUAGULANT A.Rahimzadeh.B.sc,M.sc Shahid Beheshty university

What is Anticoagulation? Anticoagulation: blocking, suppression or delaying of clotting of the blood Clot formation occurs when blood contact “foreign” surface,such as: Blood enters the bloodlines & dialyzer

What cause blood to clot? Clotting is a part of complex body process: Hemostasis Hemostasis involves: Retraction and contraction of the injured vessel Platelets to stick to the injured area A complex interaction of coagulation factor Coagulation factor: present in normal blood identify by roman numerals

Clotting of the ExtraCorporeal Circuit : Favoring Factors High Ultra Filtration Rate High Hematocrit Problems With a Dialysis Access Blood and Blood Product Transfusion Intradialytic Lipid Infusion Use of Drip Chambers Low Blood Flow

Assessing Coagulation During Dialysis Visual Inspection ExtraCorporeal Circuit Pressures Dialyzer Appearance After Dialysis Clotting Time Tests

Visual Inspection: Signs of Clotting in the ExtraCorporeal Circuit Extremely Dark Blood Shadows or Black Streaks in the Dialyzer Foaming with Subsequent Clot Formation in Drip Chambers and Venous Trap Presence of Clots at the Arterial-Side Dialyzer

ExtraCorporeal Circuit Pressures Pre-pump Arterial Pressure Post-pump arterial Pressure Venous Pressure Increase Post-pump Arterial Pressure & Decrease Venous Pressure Increase Post-pump Arterial Pressure & Increase Venous Pressure

Dialyzer Appearance After Dialysis Determine of Dialyzer Clotting Grade * Grade 1: rate of Clotting < 10% * Grade 2: rate of Clotting < 50% * Grade 3: rate of Clotting > 50 % Report of High Grade Clotting

Clotting Time Tests Whole- Blood Partial Thromboplastin Time (WBPTT) Activated Clotting Time (ACT) Lee-White Clotting Time (LWCT)

Goal Clotting Time In Hemodialysis Normal Range :60-85 s During Dialysis:+80% (120-140 s) Normal Range:120-150 s (200-250 s) Normal Range: 4-8 m During Dialysis:20-30 m Whole- Blood Partial Thromboplastin Time Activated Clotting Time Lee-White Clotting Time

تجویز هپارین به مقدار کم Goal Clotting Time in Hemodialysis تجویز هپارین به مقدار کم تجویز روتین هپارین میزان مطلوب پایان دیالیز حین دیالیز میزان طبیعی نوع آزمایش +40% (85-105)" (85-105)'' %80+ (120-140)” 60”-85” WBPTT %40+ (170-190)” (200-250)” 120”-150” ACT 9-16' 20-30' 4'-8' LWCT

Which tests are best for HD? Lee- white clotting time: Long clotting time involved Poor standardization Poor reproducibility PTT: Must be performed in laboratory Is reliable only at lower levels of Heparin ACT: Easily used in dialysis

Anticoagulation Techniques Routine Heparin: a- Constant–infusion method b- Repeated–bolus method Tight Heparin Heparin-Free Dialysis Regional Anticoagulation with Protamin Reversal Regional Citrate Anticoagulation Regional Prostacyclin Anticoagulation Recombinant Hirudin Anticoagulation Low Molecular Weight Heparin

Routine Heparin 1- Constant–infusion method Bolus : 2000 & infusion: 1200 IU/hr Control Clotting Time: every hour Discontinue infusion: 1 hour before the termination of Dialysis 2- Repeated–bolus method Primary Bolus: 4000 IU Additional Bolus Dose: 1000-2000 IU

Tight Heparin Indications: gastritis, Peptic Ulcer, Diabetic Retinopathy, First Dialysis, … 1- Constant–infusion method Primary Bolus: 750 IU infusion Rate: 600 IU/hr 2- Repeated–Bolus method Primary Bolus: 1000 IU Bolus: 500 IU/hr

Heparin- Free Dialysis: Indications Pericarditis Recent Surgery: Vascular/Cardiac Surgery Eye Surgery Renal Transplant Brain Surgery Coagulopathy Thrombocytopenia Intracerebral Hemorrhage Active Bleeding

Heparin-Free Dialysis Heparin Prime (2000-5000 IU/1000 cc Nacl ) Prime without heparin BF: 250-500ml/min Nacl falsh every 25-30 min ( 25-30 cc)

Primary Bolus: 25-50 IU/kg (50 > Body weight >90 ) Heparin Dosage 1- Heparin dosage prescribe base on DW: Primary Bolus: 25-50 IU/kg (50 > Body weight >90 ) Bolus : 1000-2000 IU/hr 2- Dosage adjustment need if there is a change in: Patient dry weight Length of treatment Dialyzer membrane EPO Dosage Urea clearance

Blood Transfusion in Heparin-free dialysis BT can complicate Heparin-free dialysis Blood Transfusion: increases viscosity of the blood Infuse normal clotting factor Solution: Saline rinses Other parameters remain like Heparin-free Dilalysis

Vascular Catheter & Heparin Lock After Dialsis : Flush each lumen of the catheter with 10 ml normal saline Instill a prescribed volume of heparin in lumen Clamp the lumen immediately

Clotting Factors: Technical or Operator-Induced Dialyzer Priming Retained Air in Dialyzer Lack or Inadequate Priming of Heparin Infusion Line Heparin Administration Incorrect Heparin Pump Setting Incorrect Loading Dose Delayed Starting of Heparin Pump Failure to Release Heparin Line Clamp Improper Time Lapse after Loading Dose Vascular Access Inadequate Blood Flow (Needle/Catheter Positioning or Clotting) Frequent Interruption of BF(Machin alarm/Inadequate BF)

Heparin–Associated Complications Bleeding Hyperlipedemia Hyperkalemia Thrombocytopenia Pruritus

Drugs intraction with Heparin Enhance the effectiveness of heparin: Aspirin Nonstreroidal anti-inflammatory agents Dextran Decrease the effectiveness of heparin: Cardiac glycoside Nicotine Quinine Tetracycline

کلام آخر هر 100 میلی لیترخون حاوی14- 17 گرم پروتئین میباشد ! هربیمار دیالیزی درهرجلسه دیالیز 5- 10 گرم آمینواسید از دست می دهد شما چه سهمی در کاهش این رقم دارید؟ به نظر شماچه راهکاری در جهت کاهش احتمال تشکیل لخته موثرتراست؟